Erratum (DOI:10.1016/j.urology.2008.09.081);Effect of Socioeconomic Factors on Long-term Mortality in Men With Clinically Localized Prostate Cancer

Urology

Volumn 73, Issue 3, 2009, Pages 624-630

  Tewari, Ashutosh K ^a   Gold, Heather Taffet ^a   Demers, Raymond Y ^b   Johnson, Christine Cole ^c   Yadav, Rajiv ^a   Wagner, Edward H ^d   Field, Terri S ^e   Divine, George ^c   Menon, Mani ^f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Prevention   (United States)

^d MacColl Institute for Healthcare Innovation   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; HEALTH CARE ACCESS; HEALTH INSURANCE; HUMAN; INCOME; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; SOCIAL CLASS; SOCIOECONOMICS; UNIVARIATE ANALYSIS;

EID: 60849090452     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.05.014     Document Type: Erratum

References (25)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. Am Cancer Soc 57 (2007) 43-66
2. Moul J.W., Sesterhenn I.A., Connelly R.R., et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA 274 (1995) 1277-1281
3. Ward E., Jemal A., Cokkinides V., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54 (2004) 78-93
4. Godley P.A., Schenck A.P., Amamoo M.A., et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst 95 (2003) 1702-1710
5. Steenland K., Rodriguez C., Mondul A., et al. Prostate cancer incidence and survival in relation to education (United States). Cancer Causes Control 15 (2004) 939-945
6. Richardson J.T., Webster J.D., and Fields N.J. Uncovering myths and transforming realities among low-SES African-American men: implications for reducing prostate cancer disparities. J Natl Med Assoc 96 (2004) 1295-1302
7. Shavers V.L., and Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94 (2002) 334-357
8. Polednak A.P. Black-white differences in tumor grade (aggressiveness) at diagnosis of prostate cancer, 1992-1998. Ethn Dis 12 (2002) 536-540
9. Cher M.L., Lewis P.E., Banerjee M., et al. A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans. Clin Cancer Res 4 (1998) 1273-1278
10. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
11. SAS, version 8 (1999), SAS Institute, Inc, Cary, NC
12. Grossfeld G.D., Latini D.M., Downs T., et al. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol 168 (2002) 2510-2515
13. Freedland S.J., Amling C.L., Dorey F., et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 60 (2002) 670-674
14. Moul J.W., Connelly R.R., Lubeck D.P., et al. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the prostate strategic Urologic research endeavor databases. J Urol 166 (2001) 1322-1327
15. Cross C.K., Shultz D., Malkowicz S.B., et al. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol 20 (2002) 2863-2868
16. Freedland S.J., Jalkut M., Dorey F., et al. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology 56 (2000) 87-91
17. Kang J.S., Maygarden S.J., Mohler J.L., et al. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer. BJU Int 93 (2004) 1207-1210
18. Optenberg S.A., Thompson I.M., Friedrichs P., et al. Race, treatment, and long-term survival from prostate cancer in an equal access medical care delivery system. JAMA 274 (1995) 1599-1605
19. Schapira M.M., McAuliffe T.L., and Nattinger A.B. Treatment of localized prostate cancer in African-American compared with Caucasian men: less use of aggressive therapy for comparable disease. Med Care 33 (1995) 1079-1088
20. Hoffman R.M., Harlan L.C., Klabunde C.N., et al. Racial differences in initial treatment for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Gen Intern Med 18 (2003) 845-853
21. Shavers V.L., Brown M., Klabunde C.N., et al. Race/ethnicity and the intensity of medical monitoring under "watchful waiting" for prostate cancer. Med Care 42 (2004) 239-250
22. Bianco Jr. F.J., Wood Jr. D.P., Grignon D.J., et al. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy. J Urol 168 (2002) 479-482
23. Wu H., Sun L., Moul J.W., et al. Watchful waiting and factors predictive of secondary treatment of localized prostate cancer. J Urol 171 (2004) 1111-1116
24. Dale W., Vijayakumar S., Lawlor E.F., et al. Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences. Prostate 29 (1996) 271-281
25. Krieger N., Williams D.R., and Moss N.E. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Pub Health 18 (1997) 341-348